EVLV Evolv shares rise nearly 25 percent even as fourth quarter 2025 earnings lag consensus analyst expectations What management quality KimberlyClark Corporation KMB Near Highs 20260427 Alnylam Pharmaceuticals Inc ALNY Phase 2 Diabetes Drug Progress and SP 500 Contender Status Lift Bullish Outlook Armada XRPN Stock Relisting 014 20260427 US Online Youth Safety Legislative Push Big Tech Regulatory Risk Update